COMMUNIQUÉS West-GlobeNewswire

American Shared Hospital Services Announces the Sudden Passing of CEO, Peter Gaccione
13/04/2024
SAN FRANCISCO, April 12, 2024 (GLOBE NEWSWIRE) -- American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of turnkey technology solutions for stereotactic radiosurgery and advanced [...]
Better Choice Company, Inc. Announces Fourth Quarter and Full Year 2023 Results
12/04/2024
Gross Margin Improved 300 basis points to 31% Year-Over-Year Adjusted EBITDA Grew 30% Year-Over-Year EPS Grew 45% Year-Over-Year TAMPA, Fla., April 12, 2024 (GLOBE NEWSWIRE) -- Better Choice Company Inc. (NYSE American [...]
Ultragenyx Announces Update to Conference Call Timing to Discuss New Data from GTX-102 in Patients with Angelman Syndrome
12/04/2024
Conference call now scheduled for Monday, April 15 at 8:00 a.m. ET Updated registration link below NOVATO, Calif., April 12, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) today announced that [...]
International Myeloma Foundation Celebrates ODAC Meeting Outcome on Minimal Residual Disease (MRD) Testing as an Early Endpoint for the Accelerated Approval of Myeloma Drugs in Clinical Trials: A Huge Win for the Global Myeloma Community
12/04/2024
This conclusion is the result of almost 10 years of research carried out by the International Myeloma Foundation STUDIO CITY, Calif., April 12, 2024 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF) is [...]
Eagle Pharmaceuticals Announces Receipt of Notification of Deficiency from Nasdaq Regarding Requirement to Timely File Annual Report on Form 10-K
12/04/2024
WOODCLIFF LAKE, N.J., April 12, 2024 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (the “Company”) today announced that it received a notice (the “Notice”) on April 8, 2024 from the Listing [...]
Aquestive Therapeutics to Present Crossover Study Data for Libervant™ (diazepam) Buccal Film at 76th Annual Meeting of the American Academy of Neurology
12/04/2024
WARREN, N.J., April 12, 2024 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (the “Company” or “Aquestive”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' [...]
Sanofi: Information concerning the total number of voting rights and shares - March 2024
12/04/2024
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’ [...]
Sanofi: Informations relatives au nombre de droits de vote et d'actions - Mars 2024
12/04/2024
Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des Marchés Financiers Sanofi Société [...]
Nexstim Plc Resolved on a New Stock Option Plan 2024H
12/04/2024
Company Announcement, Helsinki, 12 April 2024 at 9 PM (EEST) Nexstim Plc Resolved on a New Stock Option Plan 2024H Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company") announces that the Board of Directors of Nexstim [...]
MEDIA ADVISORY: Press conferences with patients who have been charged user fees of hundreds or even thousands of dollars at for-profit surgery clinics
12/04/2024
TORONTO and LONDON and WATERLOO and BRAMPTON, Ontario, April 12, 2024 (GLOBE NEWSWIRE) -- Patients are being threatened with extremely long wait times, denied vital procedure information, and coerced or manipulated into [...]
Ontario Psychological Association Unveils New Mental Health Insights - Report
12/04/2024
TORONTO, April 12, 2024 (GLOBE NEWSWIRE) -- The Ontario Psychological Association (OPA) today released a pivotal report, “ Mental Health in Ontario: Insights from AskForHelpToday.ca ,” based on an analysis of over 12, [...]
Intermountain McKay Dee Hospital and Intermountain Medical Center Named to Fortune's 2024 Top 50 Heart Hospitals List
12/04/2024
SALT LAKE CITY and OGDEN, Utah, April 12, 2024 (GLOBE NEWSWIRE) -- Two Intermountain Health facilities have been named 2024 Top 50 Heart Hospitals in the U.S. by Fortune Magazine. Intermountain McKay-Dee Hospital in [...]
Clarification of guidance for revenue and lower than expected operating profit in the 2023/24 financial year
12/04/2024
ANNOUNCEMENT NO. 261 Clarification of guidance for revenue and lower than expected operating profit in the 2023/24 financial year According to the preliminary figures, revenue in the third quarter of 2023/24 was DKK 98. [...]
Mangoceuticals Subsidiary, MangoRx Mexico, Executes Technical Agreement with Mexican Pharmaceutical Manufacturer for Initial Development and Production of its Mango Erectile Dysfunction (ED) Products
12/04/2024
Signifies the first major step towards the application process for the certification of its Mango ED oral dissolvable products by Mexico’s health governing agency, COFEPRIS Dallas, Texas, April 12, 2024 (GLOBE NEWSWIRE [...]
Teladoc Health to Announce First Quarter 2024 Financial Results
12/04/2024
PURCHASE, NY, April 12, 2024 (GLOBE NEWSWIRE) -- Teladoc Health , Inc. (NYSE: TDOC), the global leader in whole-person virtual care, announced that it will release first quarter 2024 results on Thursday, April 25, 2024 [...]
Medicare Revises 2024 Fee Schedule to Include Payment Rate for the ReWalk Personal Exoskeleton
12/04/2024
Finalized Medicare reimbursement pathway for personal exoskeletons expands access for all eligible Medicare beneficiaries MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, April 12, 2024 (GLOBE NEWSWIRE) -- ReWalk Robotics [...]
Portage Biotech Announces Plans to Expand its Evaluation of Strategic Alternatives
12/04/2024
-Adenosine clinical development paused WESTPORT, Conn., April 12, 2024 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (NASDAQ: PRTG), a clinical-stage immuno-oncology company advancing novel multi-targeted therapies for use [...]
Compass Therapeutics Announces Poster Presentations at the Cholangiocarcinoma Foundation 2024 Annual Conference
12/04/2024
BOSTON, April 12, 2024 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple [...]
Praxis Precision Medicines to Present on Ulixacaltamide at the American Academy of Neurology 2024 Annual Meeting
12/04/2024
Innovative design of ongoing Phase 3 clinical program expected to set precedent for future clinical trials in essential tremor BOSTON, April 12, 2024 (GLOBE NEWSWIRE) -- Praxis Precision Medicines , Inc. (NASDAQ: PRAX [...]

Pages